Abstract: The disclosure relates to a viewing optic. In one embodiment, the disclosure relates to a viewing optic with an active display and an enabler interface. In one embodiment, the disclosure relates to a system comprising a viewing optic with an active display and an imaging device.

Abstract: The disclosure relates to a viewing optic with an integrated display system. In one embodiment, the viewing optic has an active display system that generates and projects the image into a first focal plane of the optical system. In yet another embodiment, the disclosure relates to a viewing optic with a power pack or battery pack.

Abstract: The disclosure relates to a viewing optic. In one embodiment, the disclosure relates to a viewing optic with an active display and a mounting system for an enabler device. In one embodiment, the disclosure relates to a viewing optic and an imaging enabler.

Abstract: The disclosure relates to a viewing optic with an integrated display system. In one embodiment, the viewing optic has an active display system that generates and projects the image into a first focal plane of the optical system. In yet another embodiment, the viewing optic has a system or device configured to track magnification setting.

Abstract: The disclosure relates to a viewing optic. In one embodiment, the disclosure relates to a viewing optic with an integrated display system. In one embodiment, the disclosure relates to a enabler configured to provide or activate or unlock select software to a viewing optic having an integrated display system.

Abstract: The disclosure relates to inhibitors of PCSK9 useful in the treatment of lipid metabolism, and other diseases in which PCSK9 plays a role, having the Formula (I): or a pharmaceutically acceptable salt, hydrate, solvate, stereoisomer, or tautomer thereof, wherein R1, X1, X2, X3, X4, X5, X6, X7, X8, X9, X10, X11, X12, and X13 are described herein.

Abstract: Provided herein are compositions, for example: oral rehydration compositions, beverages, food items, methods and uses, which utilise resistant starch to prevent or treat dehydration, including dehydration which is caused by diarrhoea. Beverages, food items and oral rehydration solutions including a resistant starch, which are suitable for aiding in the maintenance and restoration of hydration levels in individuals undertaking physical activities, including sports, are also disclosed.

Abstract: Provided herein are compositions, for example: oral rehydration compositions, beverages, food items, methods and uses, which utilise resistant starch to prevent or treat dehydration, including dehydration which is caused by diarrhoea. Beverages, food items and oral rehydration solutions including a resistant starch, which are suitable for aiding in the maintenance and restoration of hydration levels in individuals undertaking physical activities, including sports, are also disclosed.

Abstract: Devices, methods and systems are for identifying the cell type of an unknown microorganism. The device includes: an apparatus for culturing unknown organism(s), a diagnostic data acquisition tool and a computer program. The method includes: incubation of the sample with a growth medium (with or without toxins), and an analysis of the metabolites detected in the sample. The computer system compares the results collected from the device to reference metabolite profiles.

Abstract: The invention relates to new uses of PI3K inhibitors, wherein said inhibitors have an inhibitory action on the PI3K isoform delta for the treatment of immunopathology in a subject suffering from a disease or disorder selected from malaria, leishmaniasis, trypanosomiasis, toxoplasmosis and/or neurocysticercosis, via functional inhibition of TLR9 of the infected subject.

Abstract: The invention relates to dihydro-benzo-oxazine and dihydro-pyrido-oxazine compounds of the formula (I) and/or pharmaceutically acceptable salts and/or solvates thereof, wherein Y, V, W, U, Q, R1, R5, R7 and R30 are as defined in the description. Such compounds are suitable for the treatment of a disorder or disease which is mediated by the activity of the PI3K enzymes.

Abstract: The invention relates to dihydro-benzo-oxazine and dihydro-pyrido-oxazine compounds of the formula (I) and/or pharmaceutically acceptable salts and/or solvates thereof, wherein Y, V, W, U, Q, R1, R5, R7 and R30 are as defined in the description. Such compounds are suitable for the treatment of a disorder or disease which is mediated by the activity of the PI3K enzymes.

Abstract: Provided herein are compositions, for example: oral rehydration compositions, beverages, food items, methods and uses, which utilise resistant starch to prevent or treat dehydration, including dehydration which is caused by diarrhoea. Beverages, food items and oral rehydration solutions including a resistant starch, which are suitable for aiding in the maintenance and restoration of hydration levels in individuals undertaking physical activities, including sports, are also disclosed.

Abstract: A system is providing for augmenting multimedia playback on a mobile device. The system includes the mobile device and an auxiliary loudspeaker device. The mobile device includes a telecoil transmitter and is configured to, in a multimedia mode, provide a multimedia audio signal to the telecoil transmitter for transmission to the auxiliary loudspeaker device. The auxiliary loudspeaker device includes a telecoil to receive the transmitted multimedia audio signal and plays a low frequency portion of multimedia audio content at a loudspeaker of the auxiliary loudspeaker device.

Abstract: The invention relates to dihydro-benzo-oxazine and dihydro-pyrido-oxazine compounds of the formula (I) and/or pharmaceutically acceptable salts and/or solvates thereof, wherein Y, V, W, U, Q, R1, R5, R7 and R30 are as defined in the description. Such compounds are suitable for the treatment of a disorder or disease which is mediated by the activity of the PI3K enzymes.

Abstract: A system is providing for augmenting multimedia playback on a mobile device. The system includes the mobile device and an auxiliary loudspeaker device. The mobile device includes a telecoil transmitter and is configured to, in a multimedia mode, provide a multimedia audio signal to the telecoil transmitter for transmission to the auxiliary loudspeaker device. The auxiliary loudspeaker device includes a telecoil to receive the transmitted multimedia audio signal and plays a low frequency portion of multimedia audio content at a loudspeaker of the auxiliary loudspeaker device.

Abstract: A device, system and method for determining a seal quality of a sealed environment is provided herein. A seal detection device is utilized to determine a seal quality for an acoustic cavity of a microphone for a mobile device. The seal detection device determines an acoustic impedance at the end of a hollow longitudinal section by propagating a broadband audio signal from a source speaker through the hollow longitudinal section into the acoustic cavity. Located within the hollow longitudinal section is a microphone measurement portion configured to provide an output signal to measurement equipment in order to determine a transfer function between of the microphone measurement portion. Utilizing the transfer function, the seal quality can be determined for the acoustic cavity.

Abstract: The invention relates to new uses of PI3K inhibitors, wherein said inhibitors have an inhibitory action on the PI3K isoform delta for the treatment of immunopathology in a subject suffering from a disease or disorder selected from malaria, leishmaniasis, trypanosomiasis, toxoplasmosis and/or neurocysticercosis, via functional inhibition of TLR9 of the infected subject.

Abstract: The invention provides cyclo[{4-(NH2—C2H4—NH—CO—O—)Pro}-Phg-DTrp-Lys-Tyr(4-Benzyl)-Phe], optionally in protected form, or a pharmaceutically acceptable salt or complex thereof, which has interesting pharmaceutical properties.

Abstract: The invention provides cyclo[{4-(NH2—C2H4—NH—CO—O—)Pro}-Phg-DTrp-Lys-Tyr(4-Benzyl)-Phe], optionally in protected form, or a pharmaceutically acceptable salt or complex thereof, which has interesting pharmaceutical properties.